The enhancement of the immune response by pain stimulation in mice. I. The enhancement effect on PFC production via sympathetic nervous system in vivo and in vitro.
Effects of catecholamines and osmotical and physical stimuli on the induction of anti-sheep red blood cells (SRBC) plaque-forming cells (PFC) were investigated in (C57BL/6 X BALB/c)F1 mice in vivo and in vitro. The anti-SRBC PFC from mice immunized with 5 X 10(7) SRBC was markedly increased by daily s.c. injections of epinephrine. The enhancement of PFC by epinephrine was completely blocked by preadministration with propranolol and hexamethonium, but not with phentolamine. The PFC was increased by osmotic and physical stimuli given once a day for 4 days after immunization with SRBC. The enhancement of PFC by these stimuli was completely blocked by preadministration with propranolol and hexamethonium. The enhancement of PFC by physical stimuli was observed in nonimmunized mice when spleen cells from stimulated mice were cultured with SRBC in vitro. In normal mice, the enhancement of PFC was observed 2 hr after one physical stimulation. However, spleen cells from mice given two physical stimuli did not show the enhancement of PFC after treatment with anti-Thy-1.2 antibody and complement, nor after removal of nonadherent cells. Next, the serum obtained from mice 30 to 60 min after a physical stimulation enhanced PFC of normal mice spleen cells in vitro, but the enhancement was abolished by the addition of propranolol. The enhancement of anti-SRBC PFC by s.c. injection of epinephrine suggested that the autonomic nervous system, especially the sympathetic nervous system, was activated by a local stimulus effect of the injection. This enhancement of anti-SRBC PFC appear to be due to the activation of antigen non-specific helper T lymphocytes by the beta-actin of endogenous catecholamines from the adrenal gland.
D000818:Animals; D000917:Antibody Formation; D004837:Epinephrine / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007075:Immunoglobulin M / Q000096:biosynthesis; D008297:Male; D051379:Mice; D009994:Osmolar Concentration; D010146:Pain / Q000276:immunology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D012701:Serotonin / Q000494:pharmacology; D013154:Spleen / Q000276:immunology; D013564:Sympathetic Nervous System / Q000502:physiology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D013997:Time Factors
D006584:Hexamethonium Compounds; D007075:Immunoglobulin M; D011943:Receptors, Adrenergic, beta; D012701:Serotonin; D011433:Propranolol; D004837:Epinephrine; D010646:Phentolamine